Enodia Therapeutics will be attending JPM 2026 in San Francisco from January 13–16, 2026.
Yves Ribeill (CEO) and Oscar Castanon (Business Developer) will be available to connect throughout the week.
If you would like to schedule a meeting during the conference, please feel free to contact us.